The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1010
September 26, 1997
View Complete Issue         Table of Contents 2019 
Glucosamine for Osteoarthritis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Glucosamine for Osteoarthritis
September 26, 1997 (Issue: 1010)
The Medical Letter has received many inquiries about use of glucosamine, a basic constituent of articular cartilage glycosaminoglycans, for treatment of arthritis. A recently published book (The Arthritis Cure), several television news shows, and...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Glucosamine for Osteoarthritis
Article code: 1010b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.